Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2024 07:00 ET | Source: Tilray Brands, Inc.

Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities

NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and...
July 24, 2024 07:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal

Tilray Medical receives second approval for new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10.
July 22, 2024 07:00 ET | Source: Tilray Brands, Inc.

Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations

New cannabis cultivation license allows Aphria RX to cultivate a range of higher quality medical cannabis produced in Germany.